Characterisation of the main PSA glycoforms in aggressive prostate cancer

Serum levels of prostate specific antigen (PSA) are commonly used for prostate cancer (PCa) detection. However, their lack of specificity to distinguish benign prostate pathologies from PCa, or indolent from aggressive PCa have prompted the study of new non-invasive PCa biomarkers. Aberrant glycosyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Gratacós-Mulleras, Anna, Duran, Adrià, Asadi Shehni, Akram, Ferrer-Batallé, Montserrat, Ramírez, Manel, Comet, Josep, de Llorens, Rafael, Saldova, Radka, Llop, Esther, Peracaula, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643140/
https://www.ncbi.nlm.nih.gov/pubmed/33149259
http://dx.doi.org/10.1038/s41598-020-75526-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643140/
https://www.ncbi.nlm.nih.gov/pubmed/33149259
http://dx.doi.org/10.1038/s41598-020-75526-3

Ejemplares similares